Welcome to consult Elem's high-throughput CRISPR service.

86-180-6253-9203

sales@elem-bio.cn

Contact us to order

DDIT3 Knockout HEP-2 Cell Pool

Hot Products

undefined
undefined
+
  • undefined
  • undefined

Number:

LM01139175197

Product ID: LM01139175197

Market price

Selling Price:  ¥ 8499

Quantity
-
+

Stock surplus

0

Contact us to order

Antibody custom service consulting

隐藏域元素占位

  • 产品描述
  • 细胞复苏
  • 细胞传代
  • 细胞冻存
  • 抗体验证结果
    • Brand: ELEM粒曼
    • Commodity name: DDIT3 Knockout HEP-2 Cell Pool
    • Commodity ID: LM01139175197
    • Gene Symbol: DDIT3 CHOP CHOP10 GADD153
    • Ensembl ID: ENSG00000175197
    • Uniprot ID: P35638
    • 宿主细胞 / 类型: HEP-2/human laryngeal epidermoid carcinoma cells
    • NCBI Gene ID: 1649
    • 规格: 1×10^6 cells/frozen vial
    • 生长培养基: DMEM high glucose + 10% FBS + 1% P/S
    • 筛选标记: N/A
    • 生长特性: Adherent cells, epithelial-like
    • 培养条件: Incubator at 37°C with 5% CO2; passage at 1/2 to 1/4 confluence.
    • 倍增时间: ~48 hours
    • 参考换液频率: 2–3 times per week
    • 支原体检测结果: Negative
    • 敲除效率(Sanger测序): 90%
    • 蛋白质组验证结果: Protein-level validation has been completed.
    • 抗体货号: Adding...
    • 目标基因介绍: [Isoform AltDDIT3]: Product of the upstream open reading frame (uORF) of DDIT3/CHOP that is specifically produced in absence of stress, thereby preventing translation of downstream stress effector DDIT3/CHOP.||Multifunctional transcription factor in endoplasmic reticulum (ER) stress response (PubMed:15322075, PubMed:15775988, PubMed:19672300). Plays an essential role in the response to a wide variety of cell stresses and induces cell cycle arrest and apoptosis in response to ER stress (PubMed:15322075, PubMed:15775988). Plays a dual role both as an inhibitor of CCAAT/enhancer-binding protein (C/EBP) function and as an activator of other genes (By similarity). Acts as a dominant-negative regulator of C/EBP-induced transcription: dimerizes with members of the C/EBP family, impairs their association with C/EBP binding sites in the promoter regions, and inhibits the expression of C/EBP regulated genes (By similarity). Positively regulates the transcription of TRIB3, IL6, IL8, IL23, TNFRSF10B/DR5, PPP1R15A/GADD34, BBC3/PUMA, BCL2L11/BIM and ERO1L (PubMed:15775988, PubMed:17709599, PubMed:22761832, PubMed:20876114). Negatively regulates; expression of BCL2 and MYOD1, ATF4-dependent transcriptional activation of asparagine synthetase (ASNS), CEBPA-dependent transcriptional activation of hepcidin (HAMP) and CEBPB-mediated expression of peroxisome proliferator-activated receptor gamma (PPARG) (PubMed:18940792, PubMed:19672300, PubMed:20829347). Together with ATF4, mediates ER-mediated cell death by promoting expression of genes involved in cellular amino acid metabolic processes, mRNA translation and the unfolded protein response (UPR) in response to ER stress (By similarity). Inhibits the canonical Wnt signaling pathway by binding to TCF7L2/TCF4, impairing its DNA-binding properties and repressing its transcriptional activity (PubMed:16434966). Plays a regulatory role in the inflammatory response through the induction of caspase-11 (CASP4/CASP11) which induces the activation of caspase-1 (CASP1) and both these caspases increase the activation of pro-IL1B to mature IL1B which is involved in the inflammatory response (By similarity). Acts as a major regulator of postnatal neovascularization through regulation of endothelial nitric oxide synthase (NOS3)-related signaling (By similarity).
    • 细胞开发路径: A stable KO cell pool was generated using the CRISPR‑RNP approach; Sanger sequencing revealed a knockout efficiency of 90% in the cell pool.
    • 应用: A gene knockout cell pool with high knockout efficiency (KO Cell Pool) is particularly well suited for preliminary functional analyses, the development of complex disease models, precision drug screening, and broad‑scale gene discovery studies. The KO pool can be directly applied to a variety of assays and analyses without the need for time‑consuming single‑clone selection, significantly enhancing experimental throughput.
    Key words:
    • DDIT3 CHOP CHOP10 GADD153
  • 01. Preheat the complete culture medium in a 37°C water bath.
    02. Thaw the cryovial in a 37°C water bath for 1–2 minutes.
    03. Transfer the cryovials into a biosafety cabinet and wipe their surfaces with 70% ethanol.
    04. Unscrew the cap of the cryovial and gently transfer the cell suspension into a sterile centrifuge tube containing 9 mL of complete culture medium.
    05. Centrifuge at room temperature at 125g for 5–7 minutes, then discard the supernatant.
    06. Resuspend the cell pellet in 5 mL of complete culture medium, and transfer the cell suspension to a T25 culture flask.
    07. Transfer the cells to a 37°C incubator with 5% CO2 for culture.
    08. Recommended passage ratio: 1/2 to 1/4; cells reach confluence in 2–3 days.

  • 01. When the cells in the culture flask reach a confluence of 80%–90% or higher, cell passage can be performed.
    02. Remove the culture medium, PBS, and trypsin (0.25% Trypsin‑EDTA, Gibco 25200‑056) from the 4°C refrigerator, place them in a 37°C water bath, and once their temperature approaches 37°C, take them out. Spray the exterior of the bottles with 75% ethanol, then transfer them to a biosafety cabinet.

    03. Remove the culture flask to be passaged from the incubator, spray the exterior of the flask with 75% ethanol, and place it inside a biosafety cabinet.
    04. To avoid dispersing the cells, gently rinse the cells along the inner wall of the culture flask with PBS; discard the wash solution, and add 2 mL of PBS to the T25 flask.
    05. Add the appropriate volume of trypsin (1.5 mL for a T75 flask, 0.5 mL for a T25 flask), and gently swirl the flask to ensure the enzyme evenly covers the cell‑covered bottom. Adjust the volume as needed based on the specific situation. After approximately 1–2 minutes, when most of the cells have detached, add the corresponding volume of complete culture medium to stop the digestion, then use a 5‑mL pipette to gently pipette up and down until all cells are fully detached.
    06. Transfer the cell suspension to a 15 mL centrifuge tube, centrifuge at 300 × g for 5 minutes, and discard the supernatant.
    07. Transfer 5 mL of complete culture medium to resuspend the cells, adjust the seeding ratio as needed, and replenish the culture flask with complete medium—add up to 13–15 mL for a T75 flask and 5 mL for a T25 flask—then supplement with 1% double antibiotic solution.
    08. After capping the bottle and tightening the lid, gently shake the vial to ensure uniform mixing of the cells, then place it in a 37°C incubator with 5% CO2.

  • 01. Prepare the cryopreservation solution and pre-cool it in advance.
    02. Ensure that the cells to be cryopreserved meet the cryopreservation requirements, and verify the following conditions under a microscope: healthy appearance and morphological characteristics, being in the late logarithmic growth phase, and showing no signs of contamination or senescence.
    03. Digest and centrifuge the cells (refer to the subculture protocol for specific steps).
    04. Resuspend the cells in cryopreservation medium at 1 mL per tube, gently pipette up and down to ensure uniformity, then aliquot into cryovials.
    05. Place the cells in a programmed cooling box and freeze them in a −80°C freezer.
    06. Subsequently, the cells are transferred to a liquid nitrogen tank for long-term storage.

  • In antibody validation

Classification: Gene Knockout Cell Pool(WB Verified)

Cell Line Information

Gene Symbol

DDIT3 CHOP CHOP10 GADD153

NCBI Gene ID

1649

Ensembl ID

ENSG00000175197

Uniprot ID

P35638

Screening marker

N/A

Host cell/type

HEP-2/human laryngeal epidermoid carcinoma cells

Specifications

1×10^6 cells/frozen vial

Growth Medium

DMEM high glucose + 10% FBS + 1% P/S

growth characteristics

Adherent cells, epithelial-like

culture condition

Incubator at 37°C with 5% CO2; passage at 1/2 to 1/4 confluence.

doubling time

~48 hours

Reference fluid change frequency

2–3 times per week

Mycoplasma test results

Negative

Knock-out validation

Knockout efficiency (Sanger sequencing)

90%

Proteome Validation Results

Protein-level validation has been completed.

Antibody number

Adding...

Antibody validation results

In antibody validation

Cell Line Description

Introduction of target gene

[Isoform AltDDIT3]: Product of the upstream open reading frame (uORF) of DDIT3/CHOP that is specifically produced in absence of stress, thereby preventing translation of downstream stress effector DDIT3/CHOP.||Multifunctional transcription factor in endoplasmic reticulum (ER) stress response (PubMed:15322075, PubMed:15775988, PubMed:19672300). Plays an essential role in the response to a wide variety of cell stresses and induces cell cycle arrest and apoptosis in response to ER stress (PubMed:15322075, PubMed:15775988). Plays a dual role both as an inhibitor of CCAAT/enhancer-binding protein (C/EBP) function and as an activator of other genes (By similarity). Acts as a dominant-negative regulator of C/EBP-induced transcription: dimerizes with members of the C/EBP family, impairs their association with C/EBP binding sites in the promoter regions, and inhibits the expression of C/EBP regulated genes (By similarity). Positively regulates the transcription of TRIB3, IL6, IL8, IL23, TNFRSF10B/DR5, PPP1R15A/GADD34, BBC3/PUMA, BCL2L11/BIM and ERO1L (PubMed:15775988, PubMed:17709599, PubMed:22761832, PubMed:20876114). Negatively regulates; expression of BCL2 and MYOD1, ATF4-dependent transcriptional activation of asparagine synthetase (ASNS), CEBPA-dependent transcriptional activation of hepcidin (HAMP) and CEBPB-mediated expression of peroxisome proliferator-activated receptor gamma (PPARG) (PubMed:18940792, PubMed:19672300, PubMed:20829347). Together with ATF4, mediates ER-mediated cell death by promoting expression of genes involved in cellular amino acid metabolic processes, mRNA translation and the unfolded protein response (UPR) in response to ER stress (By similarity). Inhibits the canonical Wnt signaling pathway by binding to TCF7L2/TCF4, impairing its DNA-binding properties and repressing its transcriptional activity (PubMed:16434966). Plays a regulatory role in the inflammatory response through the induction of caspase-11 (CASP4/CASP11) which induces the activation of caspase-1 (CASP1) and both these caspases increase the activation of pro-IL1B to mature IL1B which is involved in the inflammatory response (By similarity). Acts as a major regulator of postnatal neovascularization through regulation of endothelial nitric oxide synthase (NOS3)-related signaling (By similarity).

Cell development path

A stable KO cell pool was generated using the CRISPR‑RNP approach; Sanger sequencing revealed a knockout efficiency of 90% in the cell pool.

Application

A gene knockout cell pool with high knockout efficiency (KO Cell Pool) is particularly well suited for preliminary functional analyses, the development of complex disease models, precision drug screening, and broad‑scale gene discovery studies. The KO pool can be directly applied to a variety of assays and analyses without the need for time‑consuming single‑clone selection, significantly enhancing experimental throughput.

Cell Culture Instructions

Cell Resuscitation

01. Preheat the complete culture medium in a 37°C water bath.
02. Thaw the cryovial in a 37°C water bath for 1–2 minutes.
03. Transfer the cryovials into a biosafety cabinet and wipe their surfaces with 70% ethanol.
04. Unscrew the cap of the cryovial and gently transfer the cell suspension into a sterile centrifuge tube containing 9 mL of complete culture medium.
05. Centrifuge at room temperature at 125g for 5–7 minutes, then discard the supernatant.
06. Resuspend the cell pellet in 5 mL of complete culture medium, and transfer the cell suspension to a T25 culture flask.
07. Transfer the cells to a 37°C incubator with 5% CO2 for culture.
08. Recommended passage ratio: 1/2 to 1/4; cells reach confluence in 2–3 days.

cell passage

01. When the cells in the culture flask reach a confluence of 80%–90% or higher, cell passage can be performed.
02. Remove the culture medium, PBS, and trypsin (0.25% Trypsin‑EDTA, Gibco 25200‑056) from the 4°C refrigerator, place them in a 37°C water bath, and once their temperature approaches 37°C, take them out. Spray the exterior of the bottles with 75% ethanol, then transfer them to a biosafety cabinet.

03. Remove the culture flask to be passaged from the incubator, spray the exterior of the flask with 75% ethanol, and place it inside a biosafety cabinet.
04. To avoid dispersing the cells, gently rinse the cells along the inner wall of the culture flask with PBS; discard the wash solution, and add 2 mL of PBS to the T25 flask.
05. Add the appropriate volume of trypsin (1.5 mL for a T75 flask, 0.5 mL for a T25 flask), and gently swirl the flask to ensure the enzyme evenly covers the cell‑covered bottom. Adjust the volume as needed based on the specific situation. After approximately 1–2 minutes, when most of the cells have detached, add the corresponding volume of complete culture medium to stop the digestion, then use a 5‑mL pipette to gently pipette up and down until all cells are fully detached.
06. Transfer the cell suspension to a 15 mL centrifuge tube, centrifuge at 300 × g for 5 minutes, and discard the supernatant.
07. Transfer 5 mL of complete culture medium to resuspend the cells, adjust the seeding ratio as needed, and replenish the culture flask with complete medium—add up to 13–15 mL for a T75 flask and 5 mL for a T25 flask—then supplement with 1% double antibiotic solution.
08. After capping the bottle and tightening the lid, gently shake the vial to ensure uniform mixing of the cells, then place it in a 37°C incubator with 5% CO2.

cell cryopreservation

01. Prepare the cryopreservation solution and pre-cool it in advance.
02. Ensure that the cells to be cryopreserved meet the cryopreservation requirements, and verify the following conditions under a microscope: healthy appearance and morphological characteristics, being in the late logarithmic growth phase, and showing no signs of contamination or senescence.
03. Digest and centrifuge the cells (refer to the subculture protocol for specific steps).
04. Resuspend the cells in cryopreservation medium at 1 mL per tube, gently pipette up and down to ensure uniformity, then aliquot into cryovials.
05. Place the cells in a programmed cooling box and freeze them in a −80°C freezer.
06. Subsequently, the cells are transferred to a liquid nitrogen tank for long-term storage.